Tabor Asset Management, LP Theravance Biopharma, Inc. Transaction History
Tabor Asset Management, LP
- $191 Million
- Q1 2025
A detailed history of Tabor Asset Management, LP transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Tabor Asset Management, LP holds 15,122 shares of TBPH stock, worth $147,741. This represents 0.07% of its overall portfolio holdings.
Number of Shares
15,122Holding current value
$147,741% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding TBPH
# of Institutions
126Shares Held
46.3MCall Options Held
600Put Options Held
300-
Madison Avenue Partners, LP New York, NY9.51MShares$92.9 Million14.29% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$72.9 Million2.02% of portfolio
-
Newtyn Management, LLC New York, NY4.76MShares$46.5 Million9.1% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$36.9 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$27 Million2.79% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $652M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...